Size | Price | Stock | Qty |
---|---|---|---|
5mg |
|
||
10mg |
|
||
25mg |
|
||
50mg |
|
||
100mg |
|
||
250mg |
|
||
Other Sizes |
|
Purity: ≥98%
SUN 1334H is a novel, potent, orally bioactive, and highly selective H1 receptor antagonist with Ki of 9.7 nM. It might be applied to the management of allergic rhinitis and conjunctivitis.
Targets |
H1 receptor ( Ki = 9.7 nM )
|
---|---|
ln Vitro |
SUN-1334H significantly inhibits histamine-induced contractions of isolated guinea-pig ileum with an IC50 (half the maximal inhibitory concentration) of 0.198 μM. SUN-1334H does not alter hERG K+-currents in CHO-K1/hERG cells at concentrations up to 100 μM[1]. SUN-1334H, cetirizine and hydroxyzine cause comparable inhibition of NLF leukocytes, IL-4 and total protein concentrations[2].
|
ln Vivo |
SUN-1334H effectively suppresses histamine and effectively prevents histamine-induced bronchospasm for 24 hours after oral administration.Ovalbumin-induced rhinitis in guinea pigs and -induced skin wheal in beagle dogs[1]. SUN-1334H exhibits a significant reduction in both passive and active cutaneous anaphylactic reactions in skin allergy models. Desloratadine and fexofenadine have no discernible effects in SUN-1334H models of central nervous system side effects[2].
|
References |
|
Molecular Formula |
C23H28CL2F2N2O3
|
---|---|
Molecular Weight |
489.382831573486
|
Exact Mass |
488.14
|
Elemental Analysis |
C, 56.45; H, 5.77; Cl, 14.49; F, 7.76; N, 5.72; O, 9.81
|
CAS # |
607736-84-5
|
Appearance |
Solid powder
|
SMILES |
C1CN(CCN1C/C=C/COCC(=O)O)C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F.Cl.Cl
|
InChi Key |
KAQMKGKFTBFMGE-SEPHDYHBSA-N
|
InChi Code |
InChI=1S/C23H26F2N2O3.2ClH/c24-20-7-3-18(4-8-20)23(19-5-9-21(25)10-6-19)27-14-12-26(13-15-27)11-1-2-16-30-17-22(28)29;;/h1-10,23H,11-17H2,(H,28,29);2*1H/b2-1+;;
|
Chemical Name |
2-[(E)-4-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]but-2-enoxy]acetic acid;dihydrochloride
|
Synonyms |
SUN-1334H; SUN1334H; SUN 1334H
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.0434 mL | 10.2170 mL | 20.4340 mL | |
5 mM | 0.4087 mL | 2.0434 mL | 4.0868 mL | |
10 mM | 0.2043 mL | 1.0217 mL | 2.0434 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.